Pasithea Therapeutics Corp.
KTTA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001841330
No open-market purchases or sales by Pasithea Therapeutics Corp. insiders were filed in the last 90 days; 25 institutions reported holding it in 13F filings for Q2 2026, worth $8.66M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Pasithea Therapeutics Corp. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 12 | 12 | 0 |
| Shares | 378.1K | 255.4K | −122.7K (−32.4%) |
| Value | $184.3K | $121.9K | −$62.4K (−33.9%) |
New holders (4)
Institutions that held Pasithea Therapeutics Corp. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 38,568 | $18.5K | 0.00% |
| XTX Topco Ltd | 10,726 | $5.14K | 0.00% |
| Naples Global Advisors, LLC | 10,620 | $5.09K | 0.00% |
| Mark Sheptoff Financial Planning, LLC | 3,323 | $1.59K | 0.00% |
Sold out (4)
Institutions that held Pasithea Therapeutics Corp. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Vanguard Group Inc | 121,007 | $59.3K |
| HRT Financial LP | 41,133 | $20.0K |
| State Street Corp | 23,647 | $11.6K |
| Jane Street Group, LLC | 14,862 | $7.28K |